Q4 2024 Teladoc Health Inc Earnings Call Transcript
Key Points
- Teladoc Health Inc (TDOC) added over 4 million members in the US in 2024, with a 6% increase in visit volumes, indicating strong customer growth and engagement.
- The company reported a successful implementation season with over 800 new clients launched on January 1, showcasing effective operational execution.
- Teladoc Health Inc (TDOC) achieved mid-teens revenue growth in its International Integrated Care business, highlighting strong performance in global markets.
- The acquisition of Catapult Health is expected to enhance Teladoc Health Inc (TDOC)'s Chronic Care management offerings, providing new growth opportunities.
- BetterHelp, a segment of Teladoc Health Inc (TDOC), served over 1 million unique paying users in 2024, demonstrating its significant market presence and consumer appeal.
- Teladoc Health Inc (TDOC) reported a full-year revenue decline of 1% in 2024 compared to 2023, indicating challenges in maintaining growth.
- The company faced a net loss per share of $5.87 for the full year, including a significant noncash goodwill impairment charge.
- BetterHelp's revenue declined by 8% in 2024, reflecting challenges in the competitive environment and impacting overall financial performance.
- The health plan channel is experiencing pressures, creating headwinds for Teladoc Health Inc (TDOC) in this segment.
- Teladoc Health Inc (TDOC) anticipates a more extended visit ramp for TRICARE, impacting expected visit volumes and revenue growth in the first half of 2025.
Good afternoon, and thank you all for attending the Teladoc Health Q4 2024 Earnings Call. My name is Brika, and I will be your moderator for today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end.
I would now like to pass the conference over to your host, Michael Minchak, Vice President Investor Relations at Teladoc Health. Thank you, you may proceed.
Thank you, and good afternoon. Today, after the market closed, we issued a press release announcing our Full Year and Fourth Quarter 2024 financial results. This press release and the accompanying slide presentation are available on the Investor Relations section of the teladochealth.com website.
On this call to discuss the results are Chuck Divita, Chief Executive Officer; and Mala Murthy, Chief Financial Officer.
During this call, we will also discuss our outlook, and our prepared remarks will be followed by a question-and-answer
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
